Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting symbols : Phio save search
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Published: 2024-04-16 (Crawled : 12:00) - phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -0.15%
H: 1.69%
C: 0.8%
pharmaceuticals for meeting
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Published: 2024-04-11 (Crawled : 12:00) - phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 3.8%
H: 1.15%
C: -1.19%
presentation cell pharmaceuticals meeting therapy
Phio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Published: 2023-10-12 (Crawled : 15:30) - globenewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -35.77%
H: 9.58%
C: 5.39%
presentation cancer pharmaceuticals immunotherapy meeting
Phio Pharmaceuticals Announces Study Results at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on November 10th and 11th
Published: 2022-11-10 (Crawled : 14:00) - investors.phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 6.63%
H: 3.0%
C: -12.9%
pharmaceuticals immunotherapy meeting cancer study
Phio Pharmaceuticals Announces Upcoming Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Published: 2022-10-06 (Crawled : 12:00) - prnewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -0.22%
H: 7.85%
C: 4.72%
pharmaceuticals immunotherapy meeting cancer
Phio Pharmaceuticals Announces Acceptance of Six Abstracts at The 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Published: 2022-09-12 (Crawled : 12:00) - prnewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -2.16%
H: 2.39%
C: -0.46%
immunotherapy meeting six cancer
Phio Pharmaceuticals Presents Study Outline of Its First Clinical Trial with PH-762 for Advanced Melanoma at the 2022 ASCO Annual Meeting
Published: 2022-06-06 (Crawled : 19:00) - prnewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -0.98%
H: 4.0%
C: -5.2%
ph-762 melanoma trial asco
Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at ASGCT 25th Annual Meeting 2022
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -4.33%
H: 5.06%
C: 0.93%
ph-894 presentation ph94
Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -2.94%
H: 175.0%
C: 167.05%
ph-894 disease positive ph94
Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at the AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - prnewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 0.91%
H: 6.25%
C: 3.72%
ph-894 als presentation ph94
Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local PH-762 Therapy at the SITC 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:00) - prnewswire.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -4.35%
H: 0.0%
C: 0.0%
positive therapy
Phio Pharmaceuticals Announces Upcoming Presentation at the SITC 36th Annual Meeting
Published: 2021-10-18 (Crawled : 15:00) - investors.phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 1.8%
H: 0.59%
C: -1.76%
presentation
Phio Pharmaceuticals Presents New In Vivo Data at the 2021 ASCO Annual Meeting Showing Dual-Targeting INTASYL Offers Increased Efficacy and Safety Potential Over Other Therapeutic Approaches
Published: 2021-06-04 (Crawled : 12:00) - investors.phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: -0.46%
H: 1.85%
C: -4.17%
potential
Phio Pharmaceuticals Announces Upcoming Data Presentations at the ASGCT and ASCO Annual Meetings
Published: 2021-04-29 (Crawled : 12:00) - investors.phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 2.47%
H: 0.0%
C: -6.02%
presentation
Phio Pharmaceuticals To Present New Data on PD-1 Targeting INTASYL at the 2021 American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-03-11 (Crawled : 13:00) - biospace.com/
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 3.17%
H: 11.26%
C: 7.51%
cancer research
Phio Pharmaceuticals Announces Three Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2020-10-26 (Crawled : 14:35) - investors.phiopharma.com
PHIO | $0.631 -1.07% 23K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.83%
therapy cancer immunotherapy
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.